Ledger.Open graph →
SEC Form D · filed December 30, 2020

ONL Therapeutics, Inc

Offering
$47.4M
Sold
$26.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

David Zacks · ANN ARBOR, MIExec · DirectorMark Hooper · ANN ARBOR, MIDirectorDavid Esposito · ANN ARBOR, MIExec · DirectorBill Burns · ANN ARBOR, MIDirectorBenjamin Tsai · Los Angeles, CAExec · DirectorXueying Wang · Austin, TXDirectorOmead K. Ostadan · Redwood City, CAExec · DirectorStella Robertson · Fort Worth, TXDirectorJoseph Lemnah · Williston, VTExec · DirectorGunther Van Dender · St. George, UTDirectorThomas E. Preston · Jamestown, KYExec · DirectorBill Burns · ANN ARBOR, MIDirectorStella Robertson · Fort Worth, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗